OmniComm Systems, Inc. signed a contracts to provide OmniComm’s proprietary TrialOne clinic automation solution to several major clinical research organizations in China. OmniComm has signed agreements for TrialOne with Xiyuan Hospital, the Chinese Anti-Cancer Association (CACA) and eStart Medical Technology Co. Ltd. The contracts represent TrialOne’s debut in China and were sparked by a strategic partnership with Tri-I Biotech (Shanghai) Inc.